Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis vs Opioids for Chronic Pain and Circulatory Disorders (CVO)
NCT03734731Not yet recruiting
- Sponsor
- American Association of Neuromuscular & Electrodiagnostic Medicine
- Start
- Jun 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of cannabis in chronic pain and cardiac morbidity, sponsored by American Association of Neuromuscular & Electrodiagnostic Medicine. Primary endpoint: Change in pain and swelling at 8 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
cannabis
03
Conditions
chronic paincardiac morbidity
Beyond the preview
Go deeper on NCT03734731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03734731.